logo-loader
IXICO PLC

Ixico leverages patient technologies and introduces wearables

Guilio Cerroni, CEO of Ixico  (LON:IXI) tells Proactive why the pharmaceuticals-serving business is expanding and why all of us  longer lives also means it's a new and expanding area for investment.
Outlining his vision for a future growth strategy Guilio tells Proactive about new forays into wearable bio-sensors and human sleep patterns as focus shifts more towards patient outcomes and much less to drugs dispensing.

Quick facts: IXICO PLC

Price: £0.52

Market: AIM
Market Cap: £24.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO sees strong topline growth in interim results

IXICO Plc's (LON:IXI) Giulio Cerroni tells Proactive that the company is seeing topline growth of 30% in a strong set of interim results. Cerroni says the company is also seeing improvements in its gross margins and cash position. He adds that the company recently raised £5.5mln...

on 23/5/18

RNS

Director/PDMR Shareholding

5 days, 22 hours ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 4 days ago

Holding(s) in Company

1 week, 5 days ago

Issue of Equity

2 weeks, 6 days ago

Directorate Change

3 weeks, 5 days ago

Director/PDMR Shareholding

3 weeks, 6 days ago

2 min read